Expanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) to Receive Quizartinib
Clinical trial NCT03746912 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03746912
- Sponsor
- Daiichi Sankyo
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.